Auris Medical to Initiate Market Launch of Bentrio™ Nasal Spray in Germany
June 28, 2021 08:30 ET
|
Auris Medical AG
Hamilton, Bermuda, June 28, 2021 – Auris Medical Holding Ltd. (NASDAQ: EARS), a company dedicated to addressing unmet medical needs through RNA therapeutics, allergy and viral infection protection,...
Inhalation & Nasal Spray Generic Drugs Market at CAGR of 8.29% by 2031: Visiongain Research Inc.
June 17, 2021 12:30 ET
|
Visiongain Ltd
Visiongain has published a new report on Inhalation & Nasal Spray Generic Drugs Market Report 2021-2031. Profiles of Inhalation & Nasal Spray Generic Drugs and Forecasts By Drug Class...
Auris Medical Starts Preparations for Covid-19 Trial with Bentrio in India
June 01, 2021 08:30 ET
|
Auris Medical AG
Hamilton, Bermuda, June 1, 2021 – Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology,...
Auris Medical Announces Positive Preclinical and Clinical Outcomes with AM-301 and Details Plans for Market Launch
April 13, 2021 07:45 ET
|
Auris Medical AG
Clinical evaluation of AM-301 nasal spray in allergic rhinitis meets primary endpoint Extended protection achieved over several hoursPreliminary preclinical data suggest therapeutic utility post...
Auris Medical Announces Initiation of Clinical Investigation of AM-301 in Allergic Rhinitis
January 29, 2021 08:30 ET
|
Auris Medical AG
Hamilton, Bermuda, January 29, 2021 – Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in...
Auris Medical Reports Positive In vitro Efficacy Data for AM-301 in Protecting Against Sars-CoV-2 Infection
December 01, 2020 09:00 ET
|
Auris Medical AG
Up to 99.4% reduction of viral titer in human epithelial cell culture (p<0.001)Results suggest potential for AM-301 nasal spray to mitigate risk of Sars-CoV-2 infection Hamilton, Bermuda, December...
Auris Medical Launches Website for AM-301-focused Subsidiary, Altamira Medica
November 20, 2020 09:10 ET
|
Auris Medical AG
Hamilton, Bermuda, November 20, 2020 – Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in...
InvestorBrandNetwork (IBN) Announces Latest Episode of Stock2Me Podcast Featuring VistaGen Therapeutics Inc. CEO Shawn Singh
October 27, 2020 08:17 ET
|
InvestorBrandNetwork (IBN)
LOS ANGELES, Oct. 27, 2020 (GLOBE NEWSWIRE) -- via InvestorWire – InvestorBrandNetwork (“IBN”), a multifaceted communications organization engaged in connecting public companies to the investment...
OTC and Personal Care Trend Report 2020 Featuring Avida, GUM, Hello Bello, Oral-B, Sopharax, Vegamour
October 26, 2020 05:33 ET
|
Research and Markets
Dublin, Oct. 26, 2020 (GLOBE NEWSWIRE) -- The "OTC and Personal Care Trend Report 2020" report has been added to ResearchAndMarkets.com's offering. Looking at the impact of wellness on...
Auris Medical Launches Development of Drug-Free Nasal Spray for Protection against Airborne Pathogens and Allergens
September 08, 2020 08:30 ET
|
Auris Medical AG
Development of AM-301 nasal spray initiated with aim of regulatory submission in 2021Key component of AM-301 shown to reduce SARS-CoV-2 viral infectious load in vitro by up to 99%Creation of dedicated...